Android app on Google Play

Allergan, Inc. (AGN) Tops Q2 EPS by 1c; Guides FY12 EPS, Revs

August 1, 2012 9:01 AM EDT Send to a Friend
Allergan, Inc. (NYSE: AGN) reported Q2 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.5 billion.

Allergan, Inc. sees FY2012 EPS of $4.15-$4.19, versus the consensus of $4.17. Allergan, Inc. sees FY2012 revenue of $5.65-$5.80 million, versus the consensus of $5.85 million.

For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment